Live Breaking News & Updates on Joint World Health Organization

Stay updated with breaking news from Joint world health organization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia


TX ), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the
Group ), today announced a strategic partnership with Plano Pte Ltd (
Plano ), a Singapore-based HealthTech startup. The collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions.
Myopia is steadily growing into one of the biggest public health challenges in the world, affecting an estimated 2.6 billion people globally, or about one-third of the world s population. By 2050, myopia is projected to affect 5 billion people, which is estimated to be about half of the world s population ....

Hong Kong , New South Wales , South Korea , Prnewswire Thomson , Mohamed Dirani , Santen Pharmaceutical Co Ltd , Thomson Eye Centre , World Health Organization , Centre For Eye Research Australia , Thomson Medical Group , Thomson Medical Group Limited The , Plano Pte Ltd , Singapore Eye Research Institute , National Health Innovation Centre , Singapore National Eye Centre , University Of New South Wales , Global Esports Federation , Thomson Medical Group Limited , Singapore Based Healthtech , Enterprise Singapore , Thomson Paediatric Clinic , Thomson Kids , High Myopia , Temporal Trends , Joint World Health Organization , Managing Director ,

Kubota Vision Provides Update on Kubota Glasses Wearable Device for Myopia Control


Posted on
530
Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company achieved a milestone by completing a first spectacle-style wearable prototype based on Kubota Glasses technology.
(1) Kubota Vision conducted a clinical study in early 2020 with an electronic tabletop optical projection device that embodied Kubota Glasses technology; (2) The company also completed a successful proof-of-concept (POC) clinical study to validate the concept of a wearable myopia-control device based on Kubota Glasses technology in August 2020; (3) Based on these results, the company has completed the first spectacle-style wearable prototype based on Kubota Glasses technology. (Photo: Business Wire) ....

Soult Ukpyolsi , South Korea , Hong Kong , New South Wales , Ryo Kubota , Hiroki Maekawa , Space Administration , Kubota Pharmaceutical Holdings , Kubota Vision Inc , World Health Organization , Drug Administration , Kubota Pharmaceutical Holdings Co Ltd , Brien Holden Vision Institute , Exchange Commission , National Aeronautics , Kubota Pharmaceutical Holdings Vision , International Myopia Institute , University Of New South Wales , Securities Exchange , Kubota Glasses Technology , Kubota Vision , Kubota Glasses , Business Wire , East Asia , Joint World Health Organization , Retin Eye ,